Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Toxoplasma gondii cylclic GMP dependent protein kinase G as a chemotherapeutic target for antiprotozoal agents

Toxoplasma gondii cylclic GMP dependent protein kinase G as a chemotherapeutic target for antiprotozoal agents

US Patent 7718390 · Granted May 18, 2010

Estimated economic value: $55,288,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Escherichia coli compositions and methods thereof2025
Neisseria meningitidis compositions and methods thereof2025
Escherichia coli compositions and methods thereof2024
Compositions and methods relating to a mutant Clostridium difficile toxin2024
Neisseria meningitidis compositions and methods thereof2023
Compositions relating to a mutant clostridium difficile toxin and methods thereo2022
Escherichia coli compositions and methods thereof2022
Compositions and methods relating to a mutant Clostridium difficile toxin2021
Compositions relating to a mutant Clostridium difficile toxin and methods thereo2021
Compositions relating to a mutant Clostridium difficile toxin and methods thereo2021
Compositions and methods relating to a mutant Clostridium difficile toxin2021
Group B Streptococcus polysaccharide-protein conjugates, methods for producing c2021